
|Articles|September 16, 2008
- November15 2004
- Volume 11
- Issue 21
Build a No-Scam Zone
Author(s)Michael Sheehan
Advertisement
Scammers think all physicians havedeep pockets, which makes them favoritetargets. Unfortunately, busy doctors don'talways have time to do due diligence, andoften end up as scam victims. To protectyourself, here are some simple rules:
- Don't do business over the phone,especially if the caller is not someone youknow personally.
- Don't respond to unsolicited financialmaterials that come by e-mail or snailmail, especially if you don't recognize thename of the company.
- Buy stocks or mutual funds onlythrough reputable brokerage firms.Check out your individual broker withthe National Association of SecuritiesDealers (800-289-9999; www.nasd.com).
- Never invest in anything you don'tfully understand. This usually puts dubiousinvestments like limited partnershipsand similar offerings off-limits.
- Be wary. Watch out for scam pitcheslike "low risk,""high yield,"or "completelysafe,"no matter who delivers it.
Even friends and colleagues can becomeunwitting scam promoters if they've beentaken in by the lure of the easy moneythat a financial scam promises.
Articles in this issue
over 17 years ago
Huge Profits for Nonprofit Physiciansover 17 years ago
Flu Shot Blues: Government-Run Health Care on Trialover 17 years ago
Arm Yourself with a Solid Strategy to Maximize Tax Returnsover 17 years ago
Are Hedge Funds Too Hot for Investors?over 17 years ago
Sort Through the Employment Statisticsover 17 years ago
Model Portfolio Series: Conservative Growthover 17 years ago
Turn Back the Clock to Gain Perspectiveover 17 years ago
Heed the Advice of Wall Street Legendsover 17 years ago
Your Own 401(k)over 17 years ago
Mixed College BagAdvertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
ACHIEVE-5: Orforglipron Improves Glycemic Control, Weight in T2D on Basal Insulin
2
VESALIUS-CV: Evolocumab Reduces Cardiovascular Events in Patients With High-Risk Diabetes
3
GLP-1 Discontinuation Cuts Chances of Meeting Weight Loss, Glycemic Goals in T2D
4
Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial
5





















































